HOME
ABOUT US
Company Profile
Honor
Public welfare undertakings
NEWS & INFORMATION
Company News
Frontiers of Medicine
Product Information
PRODUCTS
Huaier Granules
Huaiqihuang (HQH) Granule
Overview of Ongoing Research Projects
RESEARCH MATERIALS
Member Download
Public Information
CONTACT
中文版
English
Medical Frontiers
Huai Qi Huang Granules Query Method Change Description
Starting from batch HJ18 (September 18, 2018), the words "China Drug Electronic Supervision Code" in the code assignment area of small boxes and large boxes have been changed to "Code Rest assured and Traceability Code". The inquiry method has been changed from the original three methods of "telephone inquiry, short message inquiry and website inquiry" to "mobile phone Taobao scan code inquiry" and "telephone inquiry.
25
2018
/
10
Huaier Research Appears on International Stage to Sing Chinese Voice
From September 4 to 7, the 13th International Hepatobiliary and Pancreatic Association World Congress was held in Geneva, Switzerland. Nearly 3,000 delegates, including surgeons and researchers from all over the world, had a fruitful in-depth dialogue to discuss the current hot spots and difficulties in the diagnosis and treatment of hepatobiliary and pancreatic diseases in the world.
28
09
Strengthening the Construction of Big Data Cloud Platform for Scientific Research and Expecting to Provide Chinese Solutions for Human Health
The "Multicenter, Randomized Parallel Controlled Clinical Study of Huaier Granules in the Prevention of Recurrence and Metastasis after Radical Resection of Liver Cancer" by Academician Chen Xiaoping was published in Gut, the official journal of the British Society of Gastroenterology. "Er Granules" is currently the only effective drug that can prevent recurrence and metastasis after tumor surgery.
11
A real-world research program seminar on Huaier Granules for the prevention of postoperative recurrence and metastasis of colorectal cancer was held in Zhengzhou
On September 22, 2017, the "Real World Research Program Seminar on Huaier Granules for Preventing Recurrence and Metastasis of Colorectal Cancer" organized by Qidong Gaitianli Pharmaceutical Co., Ltd. was successfully held at Sheraton Zhengzhou Meisheng Hotel.
27
2017
Interpretation of Primary Liver Cancer Diagnosis and Treatment Standards and Report of Huaier Granule Research Results Seminar Held in Shanghai
On September 17, 2017, the seminar "Interpretation of Primary Liver Cancer Diagnosis and Treatment Standards and Report of Huaier Granules Research Results" organized by Gaitianli Pharmaceuticals was successfully held on the banks of the Huangpu River in the picturesque Pudong, Shanghai.
20
Special Report on the Research Results of Huaier Granules at the Seventh Hepatobiliary and Pancreatic Conference in Guangdong Province
On August 19, 2017, sponsored by the Guangdong Medical Association, undertaken by the Guangdong Provincial Hepatobiliary and Pancreatic Surgery Branch, and co-organized by the First Affiliated Hospital of Sun Yat-sen University, the 7th Academic Conference of Hepatobiliary and Pancreatic Surgery of the Guangdong Medical Association was held in Guangzhou Baiyun Wanda Hilton Hotel ", the meeting was unprecedented, with 1800 participants.
08
A real-world research program seminar on the effectiveness of Huaiqihuang granules in the treatment of primary nephrotic syndrome in children was held in Hangzhou.
On the morning of June 10, 2017, the seminar on "real world research on the effectiveness of huaiqihuang granules in the treatment of primary nephrotic syndrome in children" sponsored by qidong gaitianli pharmaceutical co., ltd. was held in Shangri-La hotel in Hangzhou city. this is the second large sample clinical study of huaiqihuang granules after the real world study of 3000 cases of bronchial asthma in children.
12
06
Real-world studies once again prove that Huaiqihuang Granules are effective in treating childhood asthma
On April 22, 2017, at the 26th National Academic Forum on Childhood Asthma and Allergy Diseases held in Beijing, Professor Liu Chuanhe, the main researcher from the Children's Hospital of the Capital Institute of Pediatrics, released the "Huaiqihuang Granules for the Treatment of Childhood Bronchial Asthma" The latest statistical analysis results of the effectiveness of real-world research.
04